Literature DB >> 8148458

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

J D Fisk1, P G Ritvo, L Ross, D A Haase, T J Marrie, W F Schlech.   

Abstract

The fatigue impact scale (FIS) was developed to improve our understanding of the effects of fatigue on quality of life. The FIS examines patients' perceptions of the functional limitations that fatigue has caused over the past month. FIS items reflect perceived impact on cognitive, physical, and psychosocial functioning. This study compared 145 patients referred for investigation of chronic fatigue (ChF) with 105 patients with multiple sclerosis (MS) and 34 patients with mild hypertension (HT). Internal consistency for the FIS and its three subscales was > .87 for all analyses. Fatigue impact was highest for the ChF group although the MS group's reported fatigue also exceeded that of the HT group. Discriminant function analysis correctly classified 80.0% of the ChF group and 78.1% of the MS group when these groups were compared. This initial validation study indicates that the FIS has considerable merit as a measure of patient's attribution of functional limitations to symptoms of fatigue.

Entities:  

Mesh:

Year:  1994        PMID: 8148458     DOI: 10.1093/clinids/18.supplement_1.s79

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  300 in total

Review 1.  Fatigue in primary biliary cirrhosis.

Authors:  Ghulam Abbas; Roberta A Jorgensen; Keith D Lindor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-11       Impact factor: 46.802

2.  Qualities of fatigue and associated chronic conditions among older adults.

Authors:  Susan E Hardy; Stephanie A Studenski
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

Review 3.  Fatigue in cholestatic liver disease--a perplexing symptom.

Authors:  D Kumar; R K Tandon
Journal:  Postgrad Med J       Date:  2002-07       Impact factor: 2.401

4.  Comparison of the psychometric properties of two fatigue scales in multiple sclerosis.

Authors:  Dagmar Amtmann; Alyssa M Bamer; Vanessa Noonan; Nina Lang; Jiseon Kim; Karon F Cook
Journal:  Rehabil Psychol       Date:  2012-05

5.  A novel approach to estimate the minimally important difference for the Fatigue Impact Scale in multiple sclerosis patients.

Authors:  Regina Rendas-Baum; Min Yang; Francoise Cattelin; Gene V Wallenstein; John D Fisk
Journal:  Qual Life Res       Date:  2010-07-10       Impact factor: 4.147

6.  Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).

Authors:  Francesco Patti; Maria Pia Amato; Maria Trojano; Stefano Bastianello; Maria Rosalia Tola; Orietta Picconi; Sabina Cilia; Salvatore Cottone; Luigi M E Grimaldi
Journal:  Qual Life Res       Date:  2011-09-28       Impact factor: 4.147

7.  Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.

Authors:  Peter J Jongen; Dirk Lehnick; Evert Sanders; Pierette Seeldrayers; Sten Fredrikson; Magnus Andersson; Joachim Speck
Journal:  Health Qual Life Outcomes       Date:  2010-11-15       Impact factor: 3.186

8.  Altered functional adaptation to attention and working memory tasks with increasing complexity in relapsing-remitting multiple sclerosis patients.

Authors:  Michael Amann; Lea Sybil Dössegger; Iris-Katharina Penner; Jochen Gunther Hirsch; Carla Raselli; Pasquale Calabrese; Katrin Weier; Ernst-Wilhelm Radü; Ludwig Kappos; Achim Gass
Journal:  Hum Brain Mapp       Date:  2010-11-12       Impact factor: 5.038

Review 9.  Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.

Authors:  Benzi M Kluger; Karen Herlofson; Kelvin L Chou; Jau-Shin Lou; Christopher G Goetz; Anthony E Lang; Daniel Weintraub; Joseph Friedman
Journal:  Mov Disord       Date:  2016-02-16       Impact factor: 10.338

10.  Ambulation and complications related to assistive devices after spinal cord injury.

Authors:  Lee L Saunders; James S Krause; Nicole D DiPiro; Sara Kraft; Sandra Brotherton
Journal:  J Spinal Cord Med       Date:  2013-04-13       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.